Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Endoscopic salvage of errantly deployed lumen-apposing metal?stents.
Interleukin-21 Receptor alpha Subunit
Mellick, William
Professional Autonomy
Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11?years.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11?years.
Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11?years. Pediatr Blood Cancer. 2022 08; 69(8):e29716.
View in:
PubMed
subject areas
Anemia, Sickle Cell
Benzaldehydes
Biomarkers
Child
Child, Preschool
Female
Hemoglobin, Sickle
Hemolysis
Humans
Male
Pyrazines
Pyrazoles
authors with profiles
Miguel Raul Abboud